321 related articles for article (PubMed ID: 33306189)
41. Circulating microRNAs: emerging biomarkers for diagnosis and prognosis in patients with gastrointestinal cancers.
Lindner K; Haier J; Wang Z; Watson DI; Hussey DJ; Hummel R
Clin Sci (Lond); 2015 Jan; 128(1):1-15. PubMed ID: 25168167
[TBL] [Abstract][Full Text] [Related]
42. Screening for pancreatic cancer in familial high-risk individuals: A systematic review.
Lu C; Xu CF; Wan XY; Zhu HT; Yu CH; Li YM
World J Gastroenterol; 2015 Jul; 21(28):8678-86. PubMed ID: 26229410
[TBL] [Abstract][Full Text] [Related]
43. Protein biomarkers for early detection of diseases: The decisive contribution of combinatorial peptide ligand libraries.
Boschetti E; D'Amato A; Candiano G; Righetti PG
J Proteomics; 2018 Sep; 188():1-14. PubMed ID: 28882677
[TBL] [Abstract][Full Text] [Related]
44. Point-of-care testing in the diagnosis of gastrointestinal cancers: current technology and future directions.
Huddy JR; Ni MZ; Markar SR; Hanna GB
World J Gastroenterol; 2015 Apr; 21(14):4111-20. PubMed ID: 25892860
[TBL] [Abstract][Full Text] [Related]
45. Validation of Biomarkers for Early Detection of Pancreatic Cancer: Summary of The Alliance of Pancreatic Cancer Consortia for Biomarkers for Early Detection Workshop.
Young MR; Wagner PD; Ghosh S; Rinaudo JA; Baker SG; Zaret KS; Goggins M; Srivastava S
Pancreas; 2018 Feb; 47(2):135-141. PubMed ID: 29346214
[TBL] [Abstract][Full Text] [Related]
46. Cancer of the gastrointestinal tract: early detection or early prevention?
Rozen P
Eur J Cancer Prev; 2004 Feb; 13(1):71-5. PubMed ID: 15075791
[TBL] [Abstract][Full Text] [Related]
47. Upper gastrointestinal tract cancers as double-cancers in elderly patients with oral squamous cell carcinoma.
Ikawa H; Tonogi M; Yamane GY; Yamauchi T; Tanaka Y; Sato M; Matsui J; Ando N; Katakura A
Bull Tokyo Dent Coll; 2012; 53(1):9-16. PubMed ID: 22452886
[TBL] [Abstract][Full Text] [Related]
48. Blood autoantibodies against tumor-associated antigens as biomarkers in early detection of colorectal cancer.
Chen H; Werner S; Tao S; Zörnig I; Brenner H
Cancer Lett; 2014 May; 346(2):178-87. PubMed ID: 24462820
[TBL] [Abstract][Full Text] [Related]
49. Identification of Serum Biomarker Panels for the Early Detection of Pancreatic Cancer.
Song J; Sokoll LJ; Pasay JJ; Rubin AL; Li H; Bach DM; Chan DW; Zhang Z
Cancer Epidemiol Biomarkers Prev; 2019 Jan; 28(1):174-182. PubMed ID: 30333219
[TBL] [Abstract][Full Text] [Related]
50. Predictive values of upper gastrointestinal cancer alarm symptoms in the general population: a nationwide cohort study.
Rasmussen S; Haastrup PF; Balasubramaniam K; Christensen RD; Søndergaard J; Jarbøl DE
BMC Cancer; 2018 Apr; 18(1):440. PubMed ID: 29669540
[TBL] [Abstract][Full Text] [Related]
51. Pattern of upper gastrointestinal tumors at Tikur Anbessa Teaching Hospital in Addis Ababa, Ethiopia: a ten-year review.
Bane A; Ashenafi S; Kassa E
Ethiop Med J; 2009 Jan; 47(1):33-8. PubMed ID: 19743778
[TBL] [Abstract][Full Text] [Related]
52. Circulating microRNA biomarkers for lung cancer detection in Western populations.
Yu H; Guan Z; Cuk K; Brenner H; Zhang Y
Cancer Med; 2018 Oct; 7(10):4849-4862. PubMed ID: 30259714
[TBL] [Abstract][Full Text] [Related]
53. Biomarkers and molecular diagnosis of gastrointestinal and pancreatic neoplasms.
Melton SD; Genta RM; Souza RF
Nat Rev Gastroenterol Hepatol; 2010 Nov; 7(11):620-8. PubMed ID: 20924366
[TBL] [Abstract][Full Text] [Related]
54. Telephone interventions for symptom management in adults with cancer.
Ream E; Hughes AE; Cox A; Skarparis K; Richardson A; Pedersen VH; Wiseman T; Forbes A; Bryant A
Cochrane Database Syst Rev; 2020 Jun; 6(6):CD007568. PubMed ID: 32483832
[TBL] [Abstract][Full Text] [Related]
55. Novel Biomarkers in the Diagnosis of Benign and Malignant Gastrointestinal Diseases.
Jonaitis P; Kiudelis V; Streleckiene G; Gedgaudas R; Skieceviciene J; Kupcinskas J
Dig Dis; 2022; 40(1):1-13. PubMed ID: 33647906
[TBL] [Abstract][Full Text] [Related]
56. Recent Advances of Functional Proteomics in Gastrointestinal Cancers- a Path towards the Identification of Candidate Diagnostic, Prognostic, and Therapeutic Molecular Biomarkers.
Abyadeh M; Meyfour A; Gupta V; Zabet Moghaddam M; Fitzhenry MJ; Shahbazian S; Hosseini Salekdeh G; Mirzaei M
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33198323
[TBL] [Abstract][Full Text] [Related]
57. Clinical trial-identified inflammatory biomarkers in breast and pancreatic cancers.
Peng J; Madduri S; Clontz AD; Stewart DA
Front Endocrinol (Lausanne); 2023; 14():1106520. PubMed ID: 37181043
[TBL] [Abstract][Full Text] [Related]
58. The utility of serum receptor-binding cancer antigen expressed on SiSo cells in gastrointestinal tract cancers.
Coban S; Ozkan H; Köklü S; Yüksel O; Koçkar MC; Akar T; Ormeci N
Can J Gastroenterol; 2006 Sep; 20(9):593-6. PubMed ID: 17001401
[TBL] [Abstract][Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
